Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates
Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5585-5595
DOI: 10.1021/acs.molpharmaceut.6c00708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.10.2026. Verfasst von Tuấn Trung Nguyễn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, University of British Columbia, 2036 Main Mall, V6T-1Z1, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Immunoconjugates, Amanitins, Alpha-Amanitin. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Alpha-amanitinthe principal toxin of Amanita phalloides, infamous for its hepatotoxicity and lethalityhas been receiving considerable attention as a candidate payload in antibody−drug conjugates (ADCs). Previously, we identified three synthetic amatoxins with heightened cytotoxicity against CHO, HEK 293, and HeLa cells. In this work, these analogs were advanced as ADC payloads using the well-established anti-HER2 antibody trastuzumab to provide a head-to-head comparative study against α-amanitin, where all payloads (synthetic or natural) are linked via a glutaric linker; esterification to the dihydroxy-isoleucine on the toxin and via an amide to an antibody lysine. Tested as ADC payloads, one synthetic amatoxin outperformed the natural toxin across various drug−antibody ratios (DARs) and across a panel of HER2-overexpressing cell lines; against SK-BR-3 cells, this ADC shows a 25-fold greater potency at DAR 2.1 compared to the same ADC linked to α-amanitin at DAR 2.0. At DAR values of 5−6, this toxin confers low-femtomolar IC50 values on the corresponding trastuzumab conjugate when assayed against SK-BR-3 cells and shows exalted cytotoxicity against a panel of HER2-overexpressing cell lines compared to the ADC linked to α-amanitin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, University of British Columbia, 2036 Main Mall, V6T-1Z1, Vancouver, British Columbia, Canada.
ORCID-Profile: Tuấn Trung Nguyễn, David M Perrin
Förderung
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Nguyễn, T. T., Froelich, J., Newell, K. C., Todorovic, M., & Perrin, D. M. (2026). Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates. Molecular Pharmaceutics, 23(11), 5585-5595. https://doi.org/10.1021/acs.molpharmaceut.6c00708
Vancouver
Nguyễn TT, Froelich J, Newell KC, Todorovic M, Perrin DM. Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates. Molecular Pharmaceutics. 2026;23(11):5585-5595. doi:10.1021/acs.molpharmaceut.6c00708
BibTeX
@article{Nguyn2026,
author = {Nguyễn, Tuấn Trung and Froelich, Juliette and Newell, Kayla C and Todorovic, Mihajlo and Perrin, David M},
title = {Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {11},
pages = {5585--5595},
doi = {10.1021/acs.molpharmaceut.6c00708}
}
EUVIMED